Example: Heart Attack

Clinical Trials on Membranous Nephropathy

Total 45 results

  • NCT04652570
    Recruiting
    Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
    Conditions: Membranous Nephropathy
  • NCT03255447
    Completed
    Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy
    Conditions: Autoimmune Membranous Nephropathy
  • NCT04629248
    Recruiting
    A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
    Conditions: Primary Membranous Nephropathy
  • NCT04733040
    Recruiting
    Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
    Conditions: Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive
  • NCT04893096
    Not yet recruiting
    Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Nephropathy Who Failed Anti-CD20 Target Therapy
    Conditions: Membranous Nephropathy
  • NCT04743739
    Recruiting
    Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
    Conditions: Idiopathic Membranous Nephropathy
  • NCT04278729
    Recruiting
    A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
    Conditions: Nephrotic Syndrome, Membranous Nephropathy
  • NCT03025828
    Completed
    Adrenocorticotropic Hormone in Membranous Nephropathy
    Conditions: Membranous Nephropathy
  • NCT04571658
    Enrolling by invitation
    NEPTUNE Match Study
    Conditions: Nephrotic Syndrome in Children, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Minimal Change Nephrotic Syndrome, Membranous Nephropathy, FSGS, MCD, MCD - Minimal Change Disease
  • NCT04745728
    Not yet recruiting
    Different Immunosuppressive Treatment in iMN
    Conditions: Idiopathic Membranous Nephropathy
  • NCT03949855
    Recruiting
    Belimumab With Rituximab for Primary Membranous Nephropathy
    Conditions: Membranous Nephropathy, MN
  • NCT01209000
    Recruiting
    Nephrotic Syndrome Study Network
    Conditions: Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
  • NCT04095156
    Recruiting
    Autoreactive B Cells in Membranous Nephropathy
    Conditions: Membranous Nephropathy
  • NCT04456816
    Recruiting
    A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN
    Conditions: Idiopathic Membranous Nephropathy
  • NCT03453619
    Active, not recruiting
    Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
    Conditions: IgA Nephropathy, Lupus Nephritis, Membranous Nephropathy, C3 Glomerulonephritis, Dense Deposit Disease
  • NCT04498962
    Not yet recruiting
    The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
    Conditions: Chronic Stable Angina, Vascular Dementia, Idiopathic Membranous Nephropathy
  • NCT03475602
    Terminated
    Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy
    Conditions: Idiopathic Membranous Nephropathy
  • NCT03285711
    Completed
    Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)
    Conditions: Lupus Membranous Nephropathy
  • NCT04326218
    Not yet recruiting
    Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
    Conditions: Membranous Nephropathy
  • NCT03929887
    Recruiting
    KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
    Conditions: Glomerular Disease, Minimal Change Disease, IgA Nephropathy, Membranous Nephropathy, Focal Segmental Glomerulosclerosis, Lupus Nephritis, Crescentic Glomerulonephritis
  • NCT03804359
    Recruiting
    Personalized Medicine for Membranous Nephropathy
    Conditions: Idiopathic Membranous Nephropathy
  • NCT01955187
    Completed
    Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
    Conditions: MEMBRANOUS NEPHROPATHY
  • NCT01386554
    Completed
    Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
    Conditions: Proteinuria, Idiopathic Membranous Nephropathy
  • NCT03864250
    Recruiting
    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
    Conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial
  • NCT01180036
    Completed
    MEmbranous Nephropathy Trial Of Rituximab
    Conditions: Idiopathic Membranous Nephropathy
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations